Regeneron Pharmaceuticals Statistics
Total Valuation
REGN has a market cap or net worth of $83.28 billion. The enterprise value is $68.17 billion.
| Market Cap | 83.28B |
| Enterprise Value | 68.17B |
Important Dates
The last earnings date was Thursday, July 30, 2026, before market open.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Aug 18, 2026 |
Share Statistics
REGN has 99.85 million shares outstanding. The number of shares has decreased by -4.76% in one year.
| Current Share Class | 98.04M |
| Shares Outstanding | 99.85M |
| Shares Change (YoY) | -4.76% |
| Shares Change (QoQ) | -1.58% |
| Owned by Insiders (%) | 3.89% |
| Owned by Institutions (%) | 93.22% |
| Float | 95.79M |
Valuation Ratios
The trailing PE ratio is 20.63 and the forward PE ratio is 13.72. REGN's PEG ratio is 1.16.
| PE Ratio | 20.63 |
| Forward PE | 13.72 |
| PS Ratio | 5.36 |
| Forward PS | 4.58 |
| PB Ratio | 2.64 |
| P/TBV Ratio | 2.74 |
| P/FCF Ratio | 22.15 |
| P/OCF Ratio | 17.79 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.50, with an EV/FCF ratio of 18.13.
| EV / Earnings | 15.75 |
| EV / Sales | 4.39 |
| EV / EBITDA | 14.50 |
| EV / EBIT | 16.33 |
| EV / FCF | 18.13 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.34 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.57 |
| Debt / FCF | 0.72 |
| Interest Coverage | 75.34 |
Financial Efficiency
Return on equity (ROE) is 14.04% and return on invested capital (ROIC) is 13.50%.
| Return on Equity (ROE) | 14.04% |
| Return on Assets (ROA) | 6.53% |
| Return on Invested Capital (ROIC) | 13.50% |
| Return on Capital Employed (ROCE) | 11.53% |
| Weighted Average Cost of Capital (WACC) | 5.17% |
| Revenue Per Employee | $1.01M |
| Profits Per Employee | $280,902 |
| Employee Count | 15,410 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.74 |
Taxes
In the past 12 months, REGN has paid $837.30 million in taxes.
| Income Tax | 837.30M |
| Effective Tax Rate | 16.21% |
Stock Price Statistics
The stock price has increased by +41.12% in the last 52 weeks. The beta is 0.19, so REGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +41.12% |
| 50-Day Moving Average | 696.27 |
| 200-Day Moving Average | 724.45 |
| Relative Strength Index (RSI) | 76.43 |
| Average Volume (20 Days) | 805,278 |
Short Selling Information
The latest short interest is 3.39 million, so 3.39% of the outstanding shares have been sold short.
| Short Interest | 3.39M |
| Short Previous Month | 3.50M |
| Short % of Shares Out | 3.39% |
| Short % of Float | 3.53% |
| Short Ratio (days to cover) | 4.15 |
Income Statement
In the last 12 months, REGN had revenue of $15.53 billion and earned $4.33 billion in profits. Earnings per share was $40.43.
| Revenue | 15.53B |
| Gross Profit | 6.91B |
| Operating Income | 4.17B |
| Pretax Income | 5.17B |
| Net Income | 4.33B |
| EBITDA | 4.70B |
| EBIT | 4.17B |
| Earnings Per Share (EPS) | $40.43 |
Balance Sheet
The company has $7.99 billion in cash and $2.71 billion in debt, with a net cash position of $15.12 billion or $151.38 per share.
| Cash & Cash Equivalents | 7.99B |
| Total Debt | 2.71B |
| Net Cash | 15.12B |
| Net Cash Per Share | $151.38 |
| Equity (Book Value) | 31.71B |
| Book Value Per Share | 316.11 |
| Working Capital | 12.92B |
Cash Flow
In the last 12 months, operating cash flow was $4.68 billion and capital expenditures -$920.90 million, giving a free cash flow of $3.76 billion.
| Operating Cash Flow | 4.68B |
| Capital Expenditures | -920.90M |
| Depreciation & Amortization | 528.60M |
| Net Borrowing | n/a |
| Free Cash Flow | 3.76B |
| FCF Per Share | $37.66 |
Margins
Gross margin is 44.46%, with operating and profit margins of 26.87% and 27.86%.
| Gross Margin | 44.46% |
| Operating Margin | 26.87% |
| Pretax Margin | 33.25% |
| Profit Margin | 27.86% |
| EBITDA Margin | 30.27% |
| EBIT Margin | 26.87% |
| FCF Margin | 24.21% |
Dividends & Yields
This stock pays an annual dividend of $3.76, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | $3.76 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.15% |
| Buyback Yield | 4.76% |
| Shareholder Yield | 5.21% |
| Earnings Yield | 5.20% |
| FCF Yield | 4.52% |
Analyst Forecast
The average price target for REGN is $840.43, which is 0.77% higher than the current price. The consensus rating is "Buy".
| Price Target | $840.43 |
| Price Target Difference | 0.77% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 11.17% |
| EPS Growth Forecast (3Y) | 15.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
REGN has an Altman Z-Score of 6.47 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.47 |
| Piotroski F-Score | 5 |